Your browser doesn't support javascript.
loading
Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages.
Huang, Wei-Chiao; Mabrouk, Moustafa T; Zhou, Luwen; Baba, Minami; Tachibana, Mayumi; Torii, Motomi; Takashima, Eizo; Locke, Emily; Plieskatt, Jordan; King, C Richter; Coelho, Camila H; Duffy, Patrick E; Long, Carole; Tsuboi, Takafumi; Miura, Kazutoyo; Wu, Yimin; Ishino, Tomoko; Lovell, Jonathan F.
Afiliação
  • Huang WC; Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
  • Mabrouk MT; Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
  • Zhou L; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
  • Baba M; Division of Molecular Parasitology, Proteo-Science Center, Ehime University, Toon, Ehime, 791-0295, Japan.
  • Tachibana M; Division of Molecular Parasitology, Proteo-Science Center, Ehime University, Toon, Ehime, 791-0295, Japan.
  • Torii M; Division of Molecular Parasitology, Proteo-Science Center, Ehime University, Toon, Ehime, 791-0295, Japan.
  • Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime, 790-8577, Japan.
  • Locke E; PATH's Malaria Vaccine Initiative (MVI), Washington, DC, 20001, USA.
  • Plieskatt J; PATH's Malaria Vaccine Initiative (MVI), Washington, DC, 20001, USA.
  • King CR; PATH's Malaria Vaccine Initiative (MVI), Washington, DC, 20001, USA.
  • Coelho CH; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
  • Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
  • Long C; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
  • Tsuboi T; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime, 790-8577, Japan.
  • Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
  • Wu Y; PATH's Malaria Vaccine Initiative (MVI), Washington, DC, 20001, USA.
  • Ishino T; Division of Molecular Parasitology, Proteo-Science Center, Ehime University, Toon, Ehime, 791-0295, Japan. tishino.vip@tmd.ac.jp.
  • Lovell JF; Department of Parasitology and Tropical Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, 113-8510, Japan. tishino.vip@tmd.ac.jp.
Commun Biol ; 5(1): 773, 2022 08 01.
Article em En | MEDLINE | ID: mdl-35915227
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Vacinas Antimaláricas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Vacinas Antimaláricas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article